Literature DB >> 19740453

Recurrent laryngeal nerve paralysis due to subclinical Lyme borreliosis.

T Karosi1, T Rácz, E Szekanecz, A Tóth, I Sziklai.   

Abstract

OBJECTIVE: We report an extremely rare case of recurrent laryngeal nerve paralysis due to subclinical Lyme borreliosis.
METHOD: Case report presenting a 15-year-old girl referred with hoarseness and soft voice.
RESULTS: Right-sided recurrent laryngeal nerve paralysis was observed using videolaryngoscopy. Imaging was used to exclude intracranial, cervical and intrathoracic embryological lesions, vascular malformations and tumours. Laboratory and electrophysiological investigations were used to exclude inflammatory and paraneoplastic processes, endocrinopathy and metabolic disorders. Serological testing was positive for Lyme disease. Parenteral ceftriaxone therapy was commenced. The patient's nerve paralysis showed complete recovery on the seventh day of antibiotic treatment; this was confirmed by videolaryngoscopy.
CONCLUSION: Recurrent laryngeal nerve paralysis is an extremely rare complication of neuroborreliosis associated with Lyme disease. In patients with recurrent laryngeal nerve paralysis in whom the clinical history is uncertain and the usual diagnostic methods give negative results, screening with anti-borrelia immunoglobulin M is suggested.

Entities:  

Mesh:

Year:  2009        PMID: 19740453     DOI: 10.1017/S0022215109990867

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  A case of Lyme neuroborreliosis with bilateral recurrent laryngeal nerve palsy.

Authors:  M Furtner; M Patjas; B Frauscher; E Schmutzhard; J Willeit
Journal:  JRSM Short Rep       Date:  2010-11-25

2.  Retrospective Evaluation of Horses Diagnosed with Neuroborreliosis on Postmortem Examination: 16 Cases (2004-2015).

Authors:  L K Johnstone; J B Engiles; H Aceto; V Buechner-Maxwell; T Divers; R Gardner; R Levine; N Scherrer; D Tewari; J Tomlinson; A L Johnson
Journal:  J Vet Intern Med       Date:  2016-06-21       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.